• Ovid Therapeutics appoints Charles Carter as new CFO The Globe and Mail Thu, 09 Jul 2026 11:30:00 GMT
• Form 4 Ovid Therapeutics Inc For: 8 July By Investing.com Investing.com Nigeria Wed, 08 Jul 2026 21:45:23 GMT
• Ovid Therapeutics (ticker: OVID) grants CFO 50,000 RSUs vesting 2027-2028 Stock Titan Wed, 08 Jul 2026 20:32:13 GMT
• Ovid Therapeutics (NASDAQ: OVID) CFO reports 44,375 shares and long-dated stock options Stock Titan Wed, 08 Jul 2026 20:28:45 GMT
• Ovid Therapeutics Says Carter Has More Than 30 Yrs of Experience Across Finance, Strategy, Operational Leadership >OVID Moomoo Wed, 08 Jul 2026 18:19:27 GMT
• PR News | On the Move: Ovid Therapeutics Hires Fort as CSO - Wed., Jul. 8, 2026 O'Dwyer's PR Wed, 08 Jul 2026 17:11:02 GMT
• Federated Hermes (NASDAQ: OVID) holds 7.74M shares, 4.15% disclosed Stock Titan Wed, 08 Jul 2026 11:55:18 GMT
• New Ovid Therapeutics (NASDAQ: OVID) CFO named as Rona transitions to consultant Stock Titan Wed, 08 Jul 2026 11:04:21 GMT
• Ovid Therapeutics Strengthens Executive Leadership Team to GlobeNewswire Wed, 08 Jul 2026 11:00:00 GMT
• Ovid Therapeutics: Risk-Adjusted Valuation Shows Deep Discount Despite 700% Rally Seeking Alpha Wed, 08 Jul 2026 01:03:09 GMT
• Ovid Therapeutics: Buy Next-Gen GABA-Aminotransferase Inhibitor OV329, TSC/IS Expansions Seeking Alpha Tue, 07 Jul 2026 20:20:27 GMT
• Companies Like Ovid Therapeutics (NASDAQ:OVID) Are In A Position To Invest In Growth simplywall.st Fri, 03 Jul 2026 14:32:01 GMT
• ovid q1 2026 earnings: narrower-than-expected loss highlights operational discipline - cash flow report dars.gov.et Fri, 03 Jul 2026 05:47:16 GMT
• Ovid Therapeutics Inc.(NasdaqCM:OVID) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Mon, 29 Jun 2026 20:59:08 GMT
• Ovid Therapeutics Inc.(NasdaqCM: OVID) added to Russell 2500 Growth Benchmark marketscreener.com Mon, 29 Jun 2026 19:32:31 GMT
• Ovid Therapeutics Inc.(NasdaqCM: OVID) added to Russell 2500 Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• ovid therapeutics inc. actuals & estimates (nasdaq:ovid) TradingView Sat, 27 Jun 2026 03:47:56 GMT
• enterprise value to revenue forward of ovid therapeutics inc. – nasdaq:ovid TradingView Thu, 25 Jun 2026 19:34:53 GMT
• Price to earnings forward of Ovid Therapeutics Inc. – NASDAQ:OVID TradingView Thu, 25 Jun 2026 18:53:42 GMT
• price to sales forward of ovid therapeutics inc. – nasdaq:ovid TradingView Thu, 25 Jun 2026 18:48:01 GMT
• ovid therapeutics inc (ovid) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 25 Jun 2026 10:51:24 GMT
• ovid therapeutics inc (ovid) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• uniQure's Experimental Drug Shows Early Promise In Difficult-To-Treat Epilepsy Sahm Tue, 23 Jun 2026 08:31:57 GMT
• ovid therapeutics inc.(nasdaqcm: ovid) added to s&p biotechnology select industry index marketscreener.com Mon, 22 Jun 2026 01:29:00 GMT
• ovid therapeutics (ovid) shares decline 6.2% as stock tests support near $2.16 - ratio spread trade dars.gov.et Sun, 21 Jun 2026 07:00:00 GMT
• ovid q1 2026 earnings: narrower-than-expected loss but stock declines 6.2% - annual financial report dars.gov.et Sat, 20 Jun 2026 07:00:00 GMT
• ovid q1 2026 earnings: narrow eps beat lightens loss, but no revenue and stock slips 6.2% - profit guidance range dars.gov.et Sat, 20 Jun 2026 07:00:00 GMT
• Ovid Therapeutics Inc (OVID) Risk Assessment: Volatility, Financial Risk & Investment Risk TradingKey Thu, 18 Jun 2026 06:46:40 GMT
• ovid therapeutics inc (ovid) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 18:49:14 GMT
• ovid therapeutics inc (ovid) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 15:26:40 GMT
• Ovid Therapeutics Inc (OVID) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey Wed, 17 Jun 2026 15:18:09 GMT
• ovid therapeutics inc (ovid) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 15:09:41 GMT
• Ovid Therapeutics (NASDAQ: OVID) grants director Anna Greka 130,000 stock options Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• ovid therapeutics inc (ovid) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Tue, 16 Jun 2026 17:50:39 GMT
• Ovid Therapeutics Inc (OVID) Shareholder Structure: Major Shareholders & Institutional Holdings TradingKey Tue, 16 Jun 2026 16:02:59 GMT
• ovid therapeutics inc (ovid) dividends & stock splits: historical payouts and event timeline TradingKey Tue, 16 Jun 2026 14:52:28 GMT
• ovid therapeutics inc (ovid) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• ovid therapeutics inc (ovid) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• ovid: multiple novel cns programs advance toward key milestones, backed by strong financial runway TradingView Mon, 15 Jun 2026 11:59:05 GMT
• OVID: Multiple clinical milestones and strong financial runway position the pipeline for significant value creation TradingView Mon, 15 Jun 2026 07:00:00 GMT
• OVID Q1 2026 Earnings: Narrower Loss Beats Estimates Amid Pre-Revenue Stage - CFO Commentary Report dars.gov.et Mon, 15 Jun 2026 07:00:00 GMT
• OVID Q1 2026 Earnings: EPS Beat Amid Pipeline Progress and Continued Cash Management - EBITDA Margin Trends dars.gov.et Fri, 12 Jun 2026 07:00:00 GMT
• ovid therapeutics shareholders back board and governance proposals The Globe and Mail Fri, 12 Jun 2026 07:00:00 GMT
• Ovid Therapeutics (NASDAQ: OVID) shareholders approve director, pay and auditor Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Ovid Therapeutics (OVID) Slips 1.97% as Shares Test Key Support Levels - Call Spread Alert dars.gov.et Thu, 11 Jun 2026 07:00:00 GMT
• ovid q1 2026 earnings: narrower loss beats estimates but stock declines on pipeline uncertainty - earnings expansion phase dars.gov.et Thu, 11 Jun 2026 07:00:00 GMT
• Ovid Therapeutics Inc Annual Shareholders Meeting Transcript GuruFocus Wed, 10 Jun 2026 07:00:00 GMT
• ovid: all proposals passed, including director election and auditor ratification, with strong quorum TradingView Wed, 10 Jun 2026 07:00:00 GMT
• Here's Why We're A Bit Worried About Voyager Therapeutics' (NASDAQ:VYGR) Cash Burn Situation Yahoo Finance Tue, 09 Jun 2026 07:00:00 GMT
• H.C. Wainwright Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $4 富途牛牛 Mon, 08 Jun 2026 07:00:00 GMT
• Ovid Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire Thu, 04 Jun 2026 07:00:00 GMT
• ovid board move puts scientific strategy back in focus Kalkine Media Thu, 04 Jun 2026 07:00:00 GMT
• biotech ovid therapeutics joins june neuro investor conferences Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• ovid therapeutics expands board, appoints new scientific director The Globe and Mail Thu, 04 Jun 2026 07:00:00 GMT
• ovid therapeutics appoints anna greka to board, creates science and technology committee citybiz Wed, 03 Jun 2026 17:02:21 GMT
• ovid therapeutics appoints harvard professor dr. anna greka to board of directors geneonline.com Wed, 03 Jun 2026 11:21:33 GMT
• Ovid Therapeutics Appoints Leading Physician-Scientist and GlobeNewswire Wed, 03 Jun 2026 07:00:00 GMT
• ovid therapeutics appoints anna greka to board of directors Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• press release: ovid therapeutics appoints leading physician-scientist and biotech innovator anna greka, m.d., ph.d., to board of d... Moomoo Wed, 03 Jun 2026 07:00:00 GMT
• anna greka joins ovid therapeutics (nasdaq: ovid) board, expanding it to seven Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• Ovid Therapeutics (OVID) Edges Higher: Key Levels in Focus - Volume Climax dars.gov.et Fri, 29 May 2026 07:00:00 GMT
• Biotech veteran Jeremy Levin on why the industry's future is secure, but American leadership is at risk STAT Thu, 28 May 2026 07:00:00 GMT
• h.c. wainwright maintains ovid therapeutics(ovid.us) with buy rating, maintains target price $4 Moomoo Tue, 26 May 2026 07:00:00 GMT
• ovid stock price, quote & chart | ovid therapeutics inc (nasdaq:ovid) ChartMill Tue, 26 May 2026 07:00:00 GMT
• we're hopeful that ovid therapeutics (nasdaq:ovid) will use its cash wisely 富途牛牛 Mon, 25 May 2026 03:30:56 GMT
• we're hopeful that ovid therapeutics (nasdaq:ovid) will use its cash wisely 富途牛牛 Tue, 19 May 2026 07:00:00 GMT
• biotech in the balance: saving a strategic industry. jeremy levin on the long run Timmerman Report Tue, 19 May 2026 07:00:00 GMT
• LifeSci Capital Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $5 富途牛牛 Sat, 16 May 2026 07:00:00 GMT
• roth mkm maintains ovid therapeutics(ovid.us) with buy rating, raises target price to $7 富途牛牛 Fri, 15 May 2026 18:59:19 GMT
• Former Ovid CEO Dr. Jeremy Levin’s rallying cry for biotech Pharma Voice Fri, 15 May 2026 07:00:00 GMT
• balyasny group holds 5.33% of ovid (nasdaq: ovid) across funds Stock Titan Fri, 15 May 2026 07:00:00 GMT
• eventide (ovid) discloses 12.8m-share, 7.3% position in ovid therapeutics Stock Titan Fri, 15 May 2026 07:00:00 GMT
• ovid therapeutics (ovid) schedule 13g: sirenia/manager report 9.9% stake Stock Titan Fri, 15 May 2026 07:00:00 GMT
• point72 (ovid) discloses shared 1.3% position, including warrants Stock Titan Fri, 15 May 2026 07:00:00 GMT
• ovid therapeutics price target raised to $7 from $5 at roth capital TipRanks Thu, 14 May 2026 15:14:59 GMT
• We're Hopeful That Ovid Therapeutics (NASDAQ:OVID) Will Use Its Cash Wisely Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• affinity asset advisors reports 9.1% stake in ovid (nasdaq: ovid) Stock Titan Thu, 14 May 2026 07:00:00 GMT
• jeremy levin reports 4.5% stake in ovid therapeutics (nasdaq: ovid) Stock Titan Thu, 14 May 2026 07:00:00 GMT
• td cowen maintains ovid therapeutics(ovid.us) with buy rating Moomoo Wed, 13 May 2026 07:31:00 GMT
• Wedbush Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $7 富途牛牛 Wed, 13 May 2026 07:00:00 GMT
• b.riley reiterates buy on ovid therapeutics stock, $5 target Investing.com Wed, 13 May 2026 07:00:00 GMT
• william blair maintains ovid therapeutics(ovid.us) with buy rating Moomoo Tue, 12 May 2026 20:31:00 GMT
• ovid sets stage for future growth with promising pipeline develo GuruFocus Tue, 12 May 2026 15:44:40 GMT
• ovid therapeutics reports first quarter 2026 business updates and financial results geneonline.com Tue, 12 May 2026 12:25:06 GMT
• ovid therapeutics : may 2026 corporate presentation marketscreener.com Tue, 12 May 2026 11:14:15 GMT
• ovid therapeutics q1 net loss widens as r&d spending rises TradingView Tue, 12 May 2026 11:11:37 GMT
• ovid therapeutics 1q research and development expenses $11.2m >ovid Moomoo Tue, 12 May 2026 11:08:00 GMT
• ovid therapeutics inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Tue, 12 May 2026 11:07:00 GMT
• Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results GlobeNewswire Tue, 12 May 2026 07:00:00 GMT
• Epilepsy drug shows favorable safety as Ovid adds pediatric seizure studies Stock Titan Tue, 12 May 2026 07:00:00 GMT
• Ovid Therapeutics earnings matched, revenue fell short of estimates Investing.com Tue, 12 May 2026 07:00:00 GMT
• Ovid Therapeutics Inc. 1Q 2026: Revenue $0M, Net loss $17M, EPS $(0.12) — 10-Q Summary TradingView Tue, 12 May 2026 07:00:00 GMT
• Ovid Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary TradingView Tue, 12 May 2026 07:00:00 GMT
• ovid therapeutics stock rises 4% on in-line results, pipeline progress Investing.com Tue, 12 May 2026 07:00:00 GMT
• ovid therapeutics (nasdaq: ovid) extends cash runway into 2029 Stock Titan Tue, 12 May 2026 07:00:00 GMT
• ovid therapeutics reports q1 2026 results, advances ov329 and ov4071 clinical programs, and expands pipeline for pediatric epileps... Minichart Tue, 12 May 2026 07:00:00 GMT
• ovid: advancing novel therapies for seizures and psychosis with strong safety and market potential TradingView Tue, 12 May 2026 07:00:00 GMT
• ovid therapeutics (nasdaq: ovid) widens q1 loss but boosts cash to $165.6m Stock Titan Tue, 12 May 2026 07:00:00 GMT
• here is why ovid therapeutics (ovid) is one of the best fast growing penny stocks Insider Monkey Sun, 10 May 2026 04:04:36 GMT
• ovid therapeutics (ovid) eps diluted (ttm) Zacks Investment Research Sat, 09 May 2026 14:39:33 GMT
• Here is Why Ovid Therapeutics (OVID) is One of the Best Fast Growing Penny Stocks Yahoo Finance Sat, 09 May 2026 07:00:00 GMT
• ovid therapeutics inc expected to post a loss of 12 cents a share - earnings preview TradingView Fri, 08 May 2026 15:36:24 GMT
• ovid sec filings - ovid therapeutics inc 10-k, 10-q, 8-k forms Stock Titan Fri, 01 May 2026 14:28:39 GMT
• ovid therapeutics (nasdaq:ovid) sees large decline in short interest MarketBeat Wed, 29 Apr 2026 23:17:21 GMT
• ovid therapeutics advances ov329 epilepsy drug, secures $60m financing MSN Wed, 29 Apr 2026 13:53:06 GMT
• ovid earnings history & surprises | eps & revenue results | ovid therapeutics inc (nasdaq:ovid) ChartMill Wed, 29 Apr 2026 07:00:00 GMT
• ovid therapeutics advances ov329 epilepsy drug, secures $60m financing MSN Tue, 28 Apr 2026 22:08:14 GMT
• ovid therapeutics (nasdaq: ovid) registers 29.9m resale shares from private placement Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• ovid therapeutics (nasdaq: ovid) outlines 2026 virtual meeting, pay and audit votes Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• ovid therapeutics advances ov329 epilepsy drug, secures $60m financing MSN Sun, 26 Apr 2026 17:25:55 GMT
• ovid therapeutics advances ov329 epilepsy drug, secures $60m financing MSN Fri, 24 Apr 2026 05:46:33 GMT
• ovid therapeutics advances ov329 epilepsy drug, secures $60m financing MSN Thu, 23 Apr 2026 09:55:02 GMT
• ovid ovid therapeutics inc. far exceeds q4 2025 eps expectations, shares rise nearly four percent. - margin compression UBND thành phố Hải Phòng Thu, 23 Apr 2026 02:44:21 GMT
• ovid (ovid therapeutics) delivers blowout q4 2025 results, but stock dips slightly amid mild investor profit taking. - social trad... UBND thành phố Hải Phòng Thu, 23 Apr 2026 00:58:53 GMT
• ovid (ovid therapeutics) delivers blowout q4 2025 results, but stock dips slightly amid mild investor profit taking. - deceleratio... Xã Châu Thành Wed, 22 Apr 2026 19:19:19 GMT
• h.c. wainwright maintains ovid therapeutics(ovid.us) with buy rating, maintains target price $4 富途牛牛 Tue, 21 Apr 2026 22:58:26 GMT
• 29.86m-share resale registration by ovid therapeutics (nasdaq: ovid) Stock Titan Tue, 21 Apr 2026 07:00:00 GMT
• ovid therapeutics receives $53.9 million from warrant exercises Investing.com Mon, 20 Apr 2026 07:00:00 GMT
• h.c. wainwright reiterates ovid therapeutics stock rating at buy Investing.com Mon, 20 Apr 2026 07:00:00 GMT
• warrant exercises bring ovid therapeutics (nasdaq: ovid) $53.9m cash Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• ovid therapeutics sees $53.9m gross proceeds as series a warrants mostly exercised TradingView Mon, 20 Apr 2026 07:00:00 GMT
• ovid therapeutics (nasdaq:ovid) given average recommendation of "buy" by analysts MarketBeat Mon, 20 Apr 2026 07:00:00 GMT
• ovid ovid therapeutics inc. far exceeds q4 2025 eps expectations, shares rise nearly four percent. - earnings turnaround Newser Sat, 18 Apr 2026 07:00:00 GMT
• william blair maintains ovid therapeutics(ovid.us) with buy rating, announces target price $5.24 富途牛牛 Sat, 18 Apr 2026 05:28:35 GMT
• lifesci capital maintains ovid therapeutics(ovid.us) with buy rating, maintains target price $5 Moomoo Fri, 17 Apr 2026 12:31:00 GMT
• william blair maintains ovid therapeutics(ovid.us) with buy rating 富途牛牛 Thu, 16 Apr 2026 09:42:09 GMT
• analysts offer insights on healthcare companies: roivant sciences (roiv), ovid therapeutics (ovid) and legend biotech (legn) The Globe and Mail Thu, 16 Apr 2026 07:00:00 GMT
• ovid.o stock news today | earnings, events & price alerts Intellectia AI Thu, 16 Apr 2026 00:52:22 GMT
• ovid reiterated by wedbush -- price target maintained at $7.00 GuruFocus Wed, 15 Apr 2026 21:33:45 GMT
Ovid Therapeutics Inc(NASDAQ:OVID) 
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase III clinical trial for the treatment of angelman syndrome in adults; and ...
Website: http://www.ovidrx.com
Founded: 2014
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology